Participants were considered eligible if they met the following inclusion criteria: adults (aged ≥18 years) with newly diagnosed, treatment-naïve, unilateral RVO (CRVO, BRVO, or hemispheric/hemicentral RVO), and who were able to understand and read English and provide informed consent. Patients who did not meet these inclusion criteria and those with other retinal diseases besides RVO or media opacities preventing adequate visualization of the retina were excluded.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.